Amgen Inc. (AMGN) News

Amgen Inc. (AMGN): $250.36

-1.23 (-0.49%)

POWR Rating

Component Grades













Add AMGN to Watchlist
Sign Up

Industry: Biotech


of 402

in industry

Filter AMGN News Items

AMGN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AMGN News Highlights

  • AMGN's 30 day story count now stands at 29.
  • Over the past 18 days, the trend for AMGN's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about AMGN are ACT, DRUG and AMG.

Latest AMGN News From Around the Web

Below are the latest news stories about AMGEN INC that investors may wish to consider to help them evaluate AMGN as an investment opportunity.

Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | January 25, 2023

Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?

Volume growth from Amgen's (AMGN) key drugs like Prolia, Otezla, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.

Yahoo | January 25, 2023

Dogs of the Dow 2023: 5 Dividend Stocks for Income Investors

The 2023 Dogs of the Dow feature several stocks investors should consider for their income portfolios.

Prakash Kolli on InvestorPlace | January 24, 2023

2 Top Passive-Income Stocks to Own in 2023

Passive-income stocks are a proven way to cushion your portfolio against market volatility. What's more, top shelf dividend plays also tend to outperform other asset classes in bull markets. Not all dividend stocks are cut from the same cloth, however.

Yahoo | January 23, 2023

3 Dividend Stocks You Can Safely Hold for Years

Most companies currently paying dividends are equipped to do so for the foreseeable future. Only a handful of dividend-paying companies, however, are built to continue dishing out dividends into the distant unknown as unforeseen changes arise. Here's a closer look at three dividend stocks you can safely hold for years.

Yahoo | January 21, 2023

Insiders who sold Amgen Inc.'s (NASDAQ:AMGN) earlier this year didn't have to weather this week's 3.1% slide

Amgen Inc.'s (NASDAQ:AMGN) value has fallen 3.1% in the last week, but insiders who sold US$5.2m worth of stock over...

Yahoo | January 21, 2023

Amgen (AMGN) Presents At 41st Annual Healthcare Conference - Slideshow (NASDAQ:AMGN)

The following slide deck was published by Amgen Inc.

Seeking Alpha | January 20, 2023

Amgen (AMGN) Gains But Lags Market: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $263.24, marking a +0.46% move from the previous day.

Yahoo | January 20, 2023

Bristol Myers Squibb Company: The Robert A. Winn Diversity in Clinical Trials Award Program Established by the Bristol Myers Squibb Foundation To Expand With Amgen''s Commitment of $8 Million

Amgen Joins Gilead Sciences as a Program SupporterApplications Now Open for Physicians and Medical StudentsOriginally published on Bristol Myers Squibb News & PerspectivesPRINCETON, NJ / ACCESSWIRE…

Finanz Nachrichten | January 19, 2023

Amgen (AMGN) Dips More Than Broader Markets: What You Should Know

Amgen (AMGN) closed at $262.03 in the latest trading session, marking a -0.89% move from the prior day.

Yahoo | January 19, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6115 seconds.